Medtronic plc (MDT) |
|
78.22 -0.73 (-0.92%)
|
09-27 16:00 |
|
Open: |
79.05 |
Pre. Close: |
78.95 |
|
High:
|
79.15 |
Low:
|
77.435 |
|
Volume:
|
5,790,642 |
Market Cap:
|
104,123(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 4:20:43 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
|
| Target: |
Six months: 95.86  One year: 99.2 |
| Support: |
Support1: 77.43 Support2: 64.42 |
| Resistance: |
Resistance1: 82.07 Resistance2: 84.94 |
| Pivot: |
80.8 |
| Moving Average: |
MA(5): 79.58 MA(20): 80.94
MA(100): 84.99 MA(250): 83.1 |
| MACD: |
MACD(12,26): -1 Signal(9): -0.8 |
| Stochastic oscillator: |
%K(14,3): 14 %D(3): 20.3 |
| RSI: |
RSI(14): 32.9 |
| 52-week: |
High: 92.01 Low: 75.76 |
| Average Vol(K): |
3-Month: 4,796 (K) 10-Days: 5,604 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MDT ] has closed below the lower bollinger band by 1.1%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ MDT ] is to continue within current trading range. Bollinger Bands are 17.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
79.67 - 80.43 |
80.43 - 80.89 |
|
Low:
|
75.8 - 76.81 |
76.81 - 77.41 |
|
Close:
|
77.12 - 78.75 |
78.75 - 79.74 |
|
Company Description |
|
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland. |
Headline News |
Wed, 27 Sep 2023
Do Traders Think Medtronic PLC (MDT) Can Turn Around Wednesday? - InvestorsObserver
Wed, 27 Sep 2023
Grimes & Company Inc. Acquires 3206 Shares of Medtronic plc ... - MarketBeat
Wed, 27 Sep 2023
Medtronic: Improved Guidance, Cheap P/E, Yield Reaches 3.5% (NYSE:MDT) - Seeking Alpha
Tue, 26 Sep 2023
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Mon, 25 Sep 2023
KFG Wealth Management LLC Takes $251000 Position in Medtronic ... - MarketBeat
Sun, 24 Sep 2023
Donaldson Capital Management LLC Buys 23142 Shares of ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
1,330 (M) |
| Shares Float |
1,330 (M) |
|
% Held by Insiders
|
0.1 (%) |
|
% Held by Institutions
|
84.5 (%) |
|
Shares Short
|
6,830 (K) |
|
Shares Short P.Month
|
6,340 (K) |
Stock Financials |
|
EPS
|
2.71 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
38.47 |
|
Profit Margin (%)
|
11.4 |
|
Operating Margin (%)
|
18.6 |
|
Return on Assets (ttm)
|
4 |
|
Return on Equity (ttm)
|
7 |
|
Qtrly Rev. Growth
|
4.5 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
23.72 |
|
EBITDA (p.s.)
|
6.26 |
|
Qtrly Earnings Growth
|
-15.7 |
|
Operating Cash Flow
|
5,830 (M) |
|
Levered Free Cash Flow
|
4,710 (M) |
Stock Valuations |
|
PE Ratio
|
28.88 |
|
PEG Ratio
|
4.5 |
|
Price to Book value
|
2.03 |
|
Price to Sales
|
3.29 |
|
Price to Cash Flow
|
17.85 |
Stock Dividends |
|
Dividend
|
0.68 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.8% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
